Publications by authors named "Silvio Sartorio"
Article Synopsis
- Revolutionary drugs have emerged in the last 5 years for hereditary angioedema (HAE), leading to better symptom control and improved quality of life for patients through innovative self-administered therapies.
- This review details currently approved treatments for HAE and future therapies under development, emphasizing advancements in understanding the disease's pathophysiology.
- New long-term prophylactic treatments and oral on-demand options aim to create personalized treatment plans, potentially allowing for attack-free remission and enhanced overall patient care.
Angioedema due to C1 inhibitor deficiency (AE-C1-INH) is a rare disease characterized by recurrent and unpredictable attacks of angioedema. Multiple trigger factors, including trauma, emotional stress, infectious diseases, and drugs, could elicit angioedema attacks. The aim of this study was to collect data on the safety and tolerability of COVID-19 vaccines in a population of patients affected by AE-C1-INH.
View Article and Find Full Text PDF